Michael Faerm

No open positions remaining

59 year

Health Technology

Finance

Consumer Services

Profile

Michael E.
Faerm is currently Chief Financial Officer at Atai Beckley, Inc. since 2026.
Former positions include Chief Financial Officer at Harpoon Therapeutics, Inc. from 2023 to 2024, Chief Financial & Accounting Officer at Viracta Therapeutics, Inc. from 2024 to 2025, Chief Financial Officer at Artiva Biotherapeutics, Inc. from 2021 to 2023, Chief Business Officer & Senior Vice President at Innoviva, Inc. from 2015 to 2018, Vice President at Merrill Lynch & Co., Inc. in 2000, Associate Director at Forest Laboratories, Inc. in 2006, Associate Director at Regeneron Pharmaceuticals, Inc. in 2004, Analyst at Credit Suisse Securities (USA) LLC from 2011 to 2013, and Analyst at Wells Fargo Securities LLC.
Education includes undergraduate studies at The Trustees of Columbia University in The City of New York, graduate studies at Stanford University, and an MBA from Harvard Business School.

Michael Faerm active positions

Companies	Position	Start

All active positions of Michael Faerm

Former positions of Michael Faerm

Companies	Position	End
VIRACTA THERAPEUTICS, INC.	Director of Finance/CFO	05/02/2025
HARPOON THERAPEUTICS, INC.	Director of Finance/CFO	01/03/2024
ARTIVA BIOTHERAPEUTICS, INC.	Director of Finance/CFO	01/03/2023
INNOVIVA, INC.	Corporate Officer/Principal	07/02/2018
FOREST LABORATORIES, INC.	Corporate Officer/Principal	01/01/2006

See the detail of Michael Faerm's experience

Training of Michael Faerm

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Faerm's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	12
Credit Suisse Securities (USA) LLC (Broker) Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Provides brokerage services	Finance
Forest Laboratories, Inc. Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells drug products	Health Technology
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases	Health Technology
The Trustees of Columbia University in The City of New York The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Stanford University Stanford University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Innoviva, Inc. Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs	Health Technology
Wells Fargo Securities LLC Wells Fargo Securities LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
Merrill Lynch & Co., Inc. Merrill Lynch & Co., Inc. Investment ManagersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services	Finance
Harvard Business School Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Harpoon Therapeutics, Inc. Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immunotherapy company that develops T-cell engagers to treat cancer and other diseases	Health Technology
Artiva Biotherapeutics, Inc. Artiva Biotherapeutics, Inc. Pharmaceuticals: OtherHealth Technology Operates as a biotechnology company which develops natural killer cell-based therapies for patients suffering from autoimmune diseases and cancers	Health Technology
Viracta Therapeutics, Inc. Viracta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for virus-associated cancers	Health Technology